Literature DB >> 30020228

Emergency general surgery in the United Kingdom: A lot of general, not many emergencies, and not much surgery.

George Ramsay1, Jared M Wohlgemut, Jan O Jansen.   

Abstract

BACKGROUND: The provision of emergency general surgery services is a global issue, with important implications for patients and workforce. The aim of this study was to analyze the characteristics of emergency general surgical patients in the United Kingdom, with reference to diagnostic case mix, operative workload, comorbidity, discharge destination, and outcomes, to facilitate comparisons and future service development.
METHODS: This is a cross-sectional population-based study based in the National Health Service in Scotland, one of the home nations of the United Kingdom. All patients aged 16 or older admitted under the care of a general surgeon, as an emergency, to a National Health Service hospital in Scotland, in 2016, were included.
RESULTS: There were 81,446 emergency general surgery admissions by 66,498 patients. Median episode age was 53 years. There were more female patients than male (55% vs 45%, p < 0.0001). The most common diagnoses were nonspecific abdominal pain (20.2%), cholecystitis (7.2%), constipation (3.4%), pancreatitis (3.1%), diverticular disease (3.1%), and appendicitis (3.1%). Only 25% of patients had operations (n = 20,292). The most frequent procedures were appendicectomy (13.1%), endoscopy (11.3%), and drainage of skin lesions (9.7%). Diagnoses and operations differed with age. Overall median length of stay was 1 day. With a 6-month follow-up, patients older than 75 years had a 19.8% mortality rate.
CONCLUSIONS: Emergency general surgery in the United Kingdom is a high-volume, diagnostically diverse, and low-operative volume specialty with high short-term mortality rate in elderly patients. Consideration should be given to alternative service delivery models, which make better use of surgeons' skills while also ensuring optimal care for patients who are increasingly elderly and have complex chronic health problems. LEVEL OF EVIDENCE: Epidemiologic study, level III.

Entities:  

Mesh:

Year:  2018        PMID: 30020228     DOI: 10.1097/TA.0000000000002010

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  6 in total

1.  Impact of deprivation and comorbidity on outcomes in emergency general surgery: an epidemiological study.

Authors:  Jared M Wohlgemut; George Ramsay; Russell L Griffin; Jan O Jansen
Journal:  Trauma Surg Acute Care Open       Date:  2020-07-27

2.  Emergency general surgery: impact of distance and rurality on mortality.

Authors:  Jared M Wohlgemut; George Ramsay; Mohamed Bekheit; Neil W Scott; Angus J M Watson; Jan O Jansen
Journal:  BJS Open       Date:  2022-03-08

3.  Twenty-year study of in-hospital and postdischarge mortality following emergency general surgical admission.

Authors:  G Ramsay; J M Wohlgemut; J O Jansen
Journal:  BJS Open       Date:  2019-07-09

4.  Causes of death after emergency general surgical admission: population cohort study of mortality.

Authors:  G Ramsay; J M Wohlgemut; M Bekheit; A J M Watson; J O Jansen
Journal:  BJS Open       Date:  2021-03-05

5.  Research priorities in emergency general surgery (EGS): a modified Delphi approach.

Authors:  Elizabeth Mary Vaughan; Robert Pearson; Jared Mark Wohlgemut; Stephen Richard Knight; Harry Spiers; Dimitrios Damaskos; Julie Cornish; Chetan Parmar; Kamal Mahawar; Susan Moug; Gian Luca Baiocchi; Fausto Catena; Gillian Tierney; Michael Samuel James Wilson
Journal:  World J Emerg Surg       Date:  2022-06-16       Impact factor: 8.165

6.  Establishing a national high fidelity cadaveric emergency urology simulation course to increase trainee preparedness for independent on-call practice: a prospective observational study.

Authors:  Nicholas Bullock; Thomas Ellul; Suzanne Biers; James Armitage; Sophia Cashman; Krishna Narahari; Oleg Tatarov; Neil Fenn; Pradeep Bose; Jonathan Featherstone; Owen Hughes
Journal:  BMC Med Educ       Date:  2020-10-07       Impact factor: 2.463

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.